"Invivyd is a biopharmaceutical company devoted to delivering protection from viral infectious diseases. By pairing state-of -the-art viral surveillance and predictive modeling with advanced antibody engineering techniques, we are committed to developing a robust pipeline of product candidate which could be used in preventive or treatment of serious viral diseases, starting with COVID-19 and expanding into influenza and other high-need indications."
